Y. Yildiz Et Al. , "High expression of mesothelin in advanced serous ovarian cancer is associated with poor prognosis," JOURNAL OF BUON , vol.24, no.4, pp.1549-1554, 2019
Yildiz, Y. Et Al. 2019. High expression of mesothelin in advanced serous ovarian cancer is associated with poor prognosis. JOURNAL OF BUON , vol.24, no.4 , 1549-1554.
Yildiz, Y., Kabadayi, G., Yigit, S., KÜÇÜKZEYBEK, Y., ALACACIOĞLU, A., Varol, U., ... Taskaynatan, H.(2019). High expression of mesothelin in advanced serous ovarian cancer is associated with poor prognosis. JOURNAL OF BUON , vol.24, no.4, 1549-1554.
Yildiz, Yasar Et Al. "High expression of mesothelin in advanced serous ovarian cancer is associated with poor prognosis," JOURNAL OF BUON , vol.24, no.4, 1549-1554, 2019
Yildiz, Yasar Et Al. "High expression of mesothelin in advanced serous ovarian cancer is associated with poor prognosis." JOURNAL OF BUON , vol.24, no.4, pp.1549-1554, 2019
Yildiz, Y. Et Al. (2019) . "High expression of mesothelin in advanced serous ovarian cancer is associated with poor prognosis." JOURNAL OF BUON , vol.24, no.4, pp.1549-1554.
@article{article, author={Yasar Yildiz Et Al. }, title={High expression of mesothelin in advanced serous ovarian cancer is associated with poor prognosis}, journal={JOURNAL OF BUON}, year=2019, pages={1549-1554} }